Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 ends winning streak as pound rises, virus fears persist

Thu, 13th Feb 2020 08:58

* FTSE 100 down 1.1%, FTSE 250 down 0.6%

* Centrica, Barclays drag on main index

* Number of coronavirus cases in China rises

* Exporters hurt by a stronger pound
(Adds news items, analyst comments, closing prices)

By Shashwat Awasthi and Noor Zainab Hussain

Feb 13 (Reuters) - London's blue-chip index fell on Thursday
after two successive days of gains, dragged down by exporters
which were hurt by a stronger pound as investors positioned for
a higher-spending budget next month under a new British finance
minister.

The FTSE 100 ended the session 1.1% lower, derailed
by steep falls in heavyweights Barclays and Centrica
, while a rise in new coronavirus cases in China jolted
broader risk sentiment.

British utility Centrica skidded 15.3% after its 2019 profit
slumped by more than a third, while Barclays slipped 1.7% as
news Britain's financial regulators were probing historical
links between the bank's chief executive officer and U.S.
financier Jeffrey Epstein overshadowed financial results.

The mid-cap FSTE 250 lost 0.6%, tracking a broader
risk-off sentiment as the Chinese province of Hubei, an
epicentre of the coronavirus outbreak, reported a record rise in
deaths and thousands of more cases.

The increase in numbers, which came after China introduced a
new diagnostic procedure involving quicker computerised
tomography (CT) scans to screen patients, dented hopes that the
outbreak would soon plateau.

After the initial outbreak roiled global markets last month,
investors have become more sensitive to the rate of escalation.

"China is the world’s largest importer of oil so the renewed
fears about the health crisis have hit stocks like BP and Royal
Dutch Shell," CMC Markets analyst David Madden said, adding that
mining stocks such as BHP, Rio Tinto and Anglo
American were hurt too.

"It has been a double whammy for the FTSE 100 as the drive
higher in sterling has dented internationally focused stocks
like GlaxoSmithKline and AstraZeneca, plus
Unilever," he said.

The midcap index was also dragged down by British gambling
firms William Hill, GVC, Playtech and
888 following a media report that the gambling
commission would consider putting limits on the amount consumers
are allowed to bet online.

All sectors of the FTSE 100 ended lower, with oil majors
Shell and BP among the major drags, followed by
financials. The index substantially underperformed the broader
European benchmark as more of its components are
exposed to commodity prices.

UAE-based NMC Health, whose shares have swung
sharply in recent sessions amid takeover chatter, tumbled 4.2%
after analysts at SocGen slapped a double rating downgrade on
the stock.

Coca Cola HBC outperformed with a 3.6% gain after
it, along with fellow bottler Coca-Cola European Partners
, reported a higher annual profit.

Small-cap drugmaker Indivior fell more than 19%
after it reported a fourth-quarter loss.
(Reporting by Shashwat Awasthi in Bengaluru; Editing by Arun
Koyyur and Shounak Dasgupta and Kirsten Donovan)

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.